Northrop Grumman Corp
NOC: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|xz | LOCK|%dn | LOCK|?klBG!#C |
Northrop Grumman Earnings: B-21 Program Charge Clouds Positive Long-Term Outlook; Shares Undervalued
Northrop Grumman's first-quarter sales declined 7% year over year to $9.5 billion, led by slower work on the B-21 bomber and winding down a few space programs. The company also booked future costs of $477 million in the B-21 program as it adapted production to tool up for future rate increases.
